Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk

IA Dialyna, S Miyakis, N Georgatou… - Oncology …, 2003 - spandidos-publications.com
Genetic polymorphisms of the genes encoding for the xenobiotic metabolizing enzymes result
in individual variations in the efficiency of detoxification of environmental carcinogens, and …

[HTML][HTML] Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study

…, N Tzanakis, A Rapti, M Gaga, N Georgatou… - Scientific Reports, 2022 - nature.com
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide accompanied by a substantial social and economic burden for the patient and …

Reduced intracellular Mg concentrations in patients with acute asthma

…, K Psathakis, P Panagou, N Georgatou… - Chest, 2003 - Elsevier
Study objectives To determine the intracellular and extracellular Mg concentrations in patients
with acute asthma and their correlation with parameters expressing the disease severity. …

Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancer

M Veslemes, D Antoniou, N Georgatou… - Anticancer …, 2005 - ar.iiarjournals.org
Background: The aim of this study was to evaluate the effectiveness of cisplatin- (CDDP)
combined chemotherapy in non-cisplatin pretreated patients with non-small-cell lung cancer (…

Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung: a phase II study.

GP Stathopoulos, M Veslemes, N Georgatou… - Anticancer …, 2003 - europepmc.org
Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung:
a phase II study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[PDF][PDF] Severe Asthma: Definitions, risk factors and phenotype characterization

P Moraitaki, D Papamichail, N Georgatou - Pneumon, 2010 - researchgate.net
Asthma is a chronic inflammatory disease of the airways characterized by recurrent episodes
of symptomatic airflow obstruction and various degrees of hyperreactivity of the airways to …

Pegylated Liposomal Doxorubicin HCL (Caelyx®) in Combination with Sandostatin LAR® as Salvage Therapy in Patients with Small-cell Lung Cancer

…, K Dilana, K Pantazopoulos, E Kotteas, N Georgatou… - In Vivo, 2006 - iv.iiarjournals.org
Background: The aim of the present study was to evaluate the efficacy of Pegylated Liposomal
Doxorubicin (Caelyx) combined with Sandostatin LAR as salvage treatment of small cell …

Follow-up of patients with severe eosinophilic asthma receiving benralizumab for one year (gReek rEAl Life regIStry of benralizuMab: REALISM Study)

…, K Katsoulis, M Kipourou, N Georgatou… - 2023 - Eur Respiratory Soc
Introduction: Benralizumab is a humanized monoclonal antibody targeting the interleukin-5
receptor (IL-5a) that is expressed on eosinophils and inhibits eosinophilic inflammation. It is …

Author Correction: Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study

…, N Tzanakis, A Rapti, M Gaga, N Georgatou… - Scientific …, 2022 - ncbi.nlm.nih.gov
… Nikolaos Koulouris, 1 Katerina Dimakou, 2 Konstantinos Gourgoulianis, 3 Nikolaos
Tzanakis, 4 Aggeliki Rapti, 5 Mina Gaga, 6 Niki Georgatou, 7 Paschalis Steiropoulos, 8 …

P2-169: Carboplatin and Gemcitabine as adjuvant therapy in completely resected stage I-IIIA non small cell lung cancer patients

…, I Tzanou, N Katirtzoglou, N Georgatou… - Journal of Thoracic …, 2007 - jto.org
Purpose: To evaluate the efficacy, toxicity and compliance associated with adjuvant Carboplatin
and Gemcitabine (CBDCA-GEM) administration in completely resected patients with …